Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Demyelination preceding a diagnosis of central nervous system lymphoma.
Protective effect of cytosolic phospholipase A2 inhibition against inflammation and degeneration by promoting regulatory T cells in rats with experimental autoimmune encephalomyelitis.
Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis.
Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis.
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.
Systematic Review and meta-analysis of the Efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in Animal Models of Stroke.
[The effect of genetic factors on the phenotypic expression of multiple sclerosis.]
NONINVASIVE ASSESSMENTS OF OPTIC NERVE NEURODEGENERATION IN TRANSGENIC MICE WITH ISOLATED OPTIC NEURITIS.
Weight status in persons with multiple sclerosis: implications for mobility outcomes.
Association of Epstein-Barr virus infection with multiple sclerosis in India.
Multiple sclerosis: Teriflunomide shows efficacy as an add-on therapy to IFN-β in patients with multiple sclerosis.
Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis.
Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
Neuropsychiatric disorders among Syrian and Iraqi refugees in Jordan: a retrospective cohort study 2012-2013.
Comparing voice self-assessment with auditory perceptual analysis in patients with multiple sclerosis.
Investigation of Fatigability during Repetitive Robot-Mediated Arm Training in People with Multiple Sclerosis.
Quantitative MRI and ultrastructural examination of the cuprizone mouse model of demyelination.
Visualization of acute focal lesions in rats with experimental autoimmune encephalomyelitis by magnetic nanoparticles, comparing different MRI sequences including phase imaging.
Disease Activity Free Status: A New End Point for a New Era in Multiple Sclerosis Clinical Research?
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary.
Functional clinical outcomes in multiple sclerosis: Current status and future prospects.
Genetic inactivation of PERK signaling in mouse oligodendrocytes: Normal developmental myelination with increased susceptibility to inflammatory demyelination.
Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy.
Pages
« first
‹ previous
…
507
508
509
510
511
512
513
514
515
…
next ›
last »